A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...
Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback